[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100433183":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":29,"responsibleParty":131,"collaborators":10,"id":133,"slug":134,"hasResults":135,"nctId":136,"briefTitle":137,"officialTitle":138,"acronym":139,"eligibilityCriteria":140,"healthyVolunteers":135,"sex":141,"minAge":10,"maxAge":10,"enrollmentInfo":142,"targetDuration":10,"studyType":145,"phases":10,"briefSummary":146,"conditions":147,"keywords":10,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":149,"lastUpdatePostDateStruct":150,"startDateStruct":153,"completionDateStruct":155,"leadSponsor":157,"locationsCount":158},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Nice","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Mitochondrial diseases",null,"annalysing with methology of multi-OMICS integration we will determined which RNA-Seq data (from muscle or fibroblasts) are the most informative for the interpretation of VUS identified by WES for patients suspected of mitochondrial myopathy.",[13],"Genetic: diagnosis of mitochondrial myopathy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"GENETIC","diagnosis of mitochondrial myopathy","• Determination of the presence of specific molecular signatures at the RNA level in muscles and fibroblasts from patients",[9],[21],{"name":22,"affiliation":5,"role":23},"SYLVIE BANNWARTH","PRINCIPAL_INVESTIGATOR",[25],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","0492034702","bannwarth.s@chu-nice.fr",[30,48,61,72,83,91,104,111,122],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"CHU de Nice","RECRUITING","Nice","CHU de NICE","06003","France","FR",{"type":39,"coordinates":40},"Point",[41,42],7.26608,43.70313,{"lat":42,"lon":41},[45,46],{"name":10,"role":26,"phone":27,"phoneExt":10,"email":28},{"name":47,"role":23,"phone":10,"phoneExt":10,"email":10},"Sylvie BANNWARTH, Professor",{"facility":49,"status":50,"city":51,"state":36,"zip":10,"country":36,"countryCode":37,"cosmosGeoPoint":52,"geoPoint":56,"contacts":57},"C.H.R.U. Brest","NOT_YET_RECRUITING","Brest",{"type":39,"coordinates":53},[54,55],-4.48628,48.39029,{"lat":55,"lon":54},[58],{"name":59,"role":60,"phone":10,"phoneExt":10,"email":10},"Jean Noury, MD","SUB_INVESTIGATOR",{"facility":62,"status":32,"city":63,"state":36,"zip":10,"country":36,"countryCode":37,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"Chu de Nantes","Nantes",{"type":39,"coordinates":65},[66,67],-1.55336,47.21725,{"lat":67,"lon":66},[70],{"name":71,"role":60,"phone":10,"phoneExt":10,"email":10},"Sandra Mercier, MD",{"facility":73,"status":32,"city":74,"state":10,"zip":10,"country":36,"countryCode":37,"cosmosGeoPoint":75,"geoPoint":79,"contacts":80},"chu Angers","Angers",{"type":39,"coordinates":76},[77,78],-0.55202,47.47156,{"lat":78,"lon":77},[81],{"name":82,"role":60,"phone":10,"phoneExt":10,"email":10},"Vincent PROCACCIO, MD",{"facility":84,"status":50,"city":51,"state":10,"zip":10,"country":36,"countryCode":37,"cosmosGeoPoint":85,"geoPoint":87,"contacts":88},"Chu Brest",{"type":39,"coordinates":86},[54,55],{"lat":55,"lon":54},[89],{"name":90,"role":60,"phone":10,"phoneExt":10,"email":10},"Pascale Marcorelles, Professor",{"facility":92,"status":32,"city":93,"state":10,"zip":10,"country":36,"countryCode":37,"cosmosGeoPoint":94,"geoPoint":98,"contacts":99},"APHM","Marseille",{"type":39,"coordinates":95},[96,97],5.38107,43.29695,{"lat":97,"lon":96},[100,102],{"name":101,"role":23,"phone":10,"phoneExt":10,"email":10},"Shahram ATTARIAN, MD",{"name":103,"role":23,"phone":10,"phoneExt":10,"email":10},"BRIGITTE CHABROL, Md",{"facility":92,"status":32,"city":93,"state":10,"zip":10,"country":36,"countryCode":37,"cosmosGeoPoint":105,"geoPoint":107,"contacts":108},{"type":39,"coordinates":106},[96,97],{"lat":97,"lon":96},[109],{"name":110,"role":60,"phone":10,"phoneExt":10,"email":10},"Shahram ATTARIAN, Professor",{"facility":112,"status":32,"city":113,"state":10,"zip":10,"country":36,"countryCode":37,"cosmosGeoPoint":114,"geoPoint":118,"contacts":119},"Chu Montpellier","Montpellier",{"type":39,"coordinates":115},[116,117],3.87635,43.61093,{"lat":117,"lon":116},[120],{"name":121,"role":60,"phone":10,"phoneExt":10,"email":10},"Cecilia MARELLI, Doctor",{"facility":123,"status":50,"city":63,"state":10,"zip":10,"country":36,"countryCode":37,"cosmosGeoPoint":124,"geoPoint":126,"contacts":127},"CHU Nantes",{"type":39,"coordinates":125},[66,67],{"lat":67,"lon":66},[128,130],{"name":129,"role":26,"phone":10,"phoneExt":10,"email":10},"Yann PEREON, Professor",{"name":129,"role":60,"phone":10,"phoneExt":10,"email":10},{"type":132,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100433183","mitomics--a-multi-omics-approach-for-the-diagnosis-of-mitochondrial-diseases-100433183",false,"NCT04920812","MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases","Interest of Multi-omics (WES \u002F RNA-Seq) Approach to Fight Against the Diagnostic Deadlock in Mitochondrial Diseases","MITOMICS","Inclusion Criteria:\n\n* Patients suspected of a mitochondrial disease with muscular signs (clinical, histological or biochemical)\n* Patients with negative mtDNA and WES NGS in trio\n* Patients with routine muscle and skin biopsies available\n* Blood samples from parents and \u002F or relatives available for segregation studies\n* Informed consent of the study signed by the patient or the legal representatives of the minor patient or under guardianship\n* Patients affiliated to social security\n\nExclusion Criteria:\n\n* Patients with suspected mitochondrial disease without muscle involvement\n* Patients for whom the mtDNA NGS and WES have not been performed\n* Patients with suspected mitochondrial disease with causal variant identified\n* Refusal to sign the informed consent for the study\n* Insufficient amount of frozen material or culture failure for fibroblasts","ALL",{"count":143,"type":144},66,"ESTIMATED","OBSERVATIONAL","MITOMICS aims to determine which RNA-Seq results (from muscle or fibroblasts) are the most informative for the interpretation of VUS identified by WES for patients suspected of mitochondrial myopathy. Analysis of RNA-Seq and WES results will performed with a computational approach using an autoencoder-based method",[148],"Mitochondrial Diseases","2025-02-21",{"date":151,"type":152},"2025-02-25","ACTUAL",{"date":154,"type":152},"2022-03-07",{"date":156,"type":144},"2025-09-07",{"name":5,"class":6},9]